JAKARTA, Indonesia, Sept. 15, 2026 /PRNewswire/ -- Bybit Indonesia, a locally regulated entity operating under the supervision of the Otoritas Jasa Keuangan (OJK), has provided support to restore education facilities and access to clean water for communities affected by the floods that hit parts of Sumatra in November 2025, in partnership with Indonesian fundraising platform Kitabisa.
The initiative spans three programs: the restoration of learning facilities at two schools in Kabupaten Langkat, North Sumatra; Yayasan Pendidikan Rahman El-Manaf Bubun and SDN 057239 Sekoci, and the construction of a borewell to restore clean water access for flood-affected communities in Desa Balee Panah, Kabupaten Bireuen, Aceh.
"Helping communities recover from a disaster requires sustained collaboration and an understanding of local needs. We appreciate Bybit Indonesia's support in helping restore school facilities in Langkat. Through this partnership, we hope to support students and teachers as they return to their daily learning activities and help families regain a sense of stability. Schools play an important role in community life, and their recovery deserves continued attention." said Vikra Ijas, Co-Founder and CEO of Kitabisa.
Restoring Learning Spaces at Yayasan Pendidikan Rahman El-Manaf Bubun
Located in Desa Bubun, Kecamatan Tanjung Pura, Kabupaten Langkat, the school serves around 187 students from elementary through high school levels, supported by 17 teachers. The area is also vulnerable to tidal flooding, adding to the challenges faced by the local community and school.
The support from Bybit Indonesia and Kitabisa covers improvements to the school's physical facilities, including floor repairs, renovation of learning areas, repainting, supporting installations, and the provision of essential classroom equipment such as desks, chairs and whiteboards.
For Yayasan Pendidikan Rahman El-Manaf Bubun, maintaining access to education is particularly important for families in the surrounding community. Many parents work as fishermen and farmers, while the school continues to provide education without imposing tuition fees or additional charges on students.
Extending Support to SDN 057239 Sekoci
Also in Kabupaten Langkat, the initiative extends to SDN 057239 Sekoci, where around 90 students and 10 teachers have benefited from facility restoration following flood damage.
Support at the school includes repairs to flooring and ceilings, repainting, electrical installation, and repairs to doors, windows and ventilation, along with the refurbishment of supporting spaces such as the library and a dedicated religious studies room. Bybit Indonesia also provided classroom learning equipment needed to support day-to-day teaching.
Restoring Access to Clean Water in Aceh
Beyond the education sector, meeting communities' basic needs has been a key focus of the recovery process. The floods damaged clean water supply infrastructure in several areas, leaving some communities struggling to access water for daily needs.
As part of its disaster donation efforts, Bybit Indonesia, together with Kitabisa, has supported the construction of a borewell in Desa Balee Panah, Kecamatan Juli, Kabupaten Bireuen, Aceh, with the process underway since July 2026. The program is expected to benefit around 125 households, or more than 400 individuals, restoring access to clean water for daily needs such as drinking, cooking, washing, and other community activities.
"Education has always been an important part of Bybit's journey, both in Indonesia and globally. When we saw the impact of the floods in Sumatra, we wanted to look at how we could make a practical contribution to the recovery — not only for children who need a safe and suitable place to learn, but also for families who need reliable access to clean water," said Lawrence Samantha, CEO of Bybit Indonesia. "Through our collaboration with Kitabisa, we've been able to direct support to where it's needed most, so communities can continue their daily lives in a better environment. Recovery takes time, and we hope this support contributes to the community's longer-term recovery."
Building Resilience Through Local Support
The initiative reflects Bybit Indonesia's broader approach to community engagement, with education and local community support forming part of its social impact efforts.
Working with local partners such as Kitabisa allows the company to direct support toward communities with specific and immediate needs. In the case of Yayasan Pendidikan Rahman El-Manaf Bubun, improving school facilities provides practical support for students, teachers and families as the wider community continues to recover from the effects of the floods.
Bybit Indonesia will continue to explore opportunities to support education and community resilience in Indonesia, alongside its ongoing focus on responsible participation in the country's digital asset ecosystem.
#Bybit / #NewFinancialPlatform
About Bybit
Bybit is The New Financial Platform.
We believe every person should have access to every financial opportunity on earth. That's why we're building the first intelligent platform that connects anyone, anywhere to the world's finance.
Trusted by more than 80 million users worldwide, Bybit brings together investing, trading, payments, and wealth-building in a single secure and intelligent ecosystem. Through the combination of AI-powered technology, deep global liquidity, robust security, and transparent operations, Bybit makes global finance more accessible, efficient, and empowering for everyone.
Built for everyone. Powered by intelligence. Open to the world.
Learn more at Bybit.com.
For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit's Communities and Social Media
Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Bybit Indonesia Supports Post-Flood Education Recovery in North Sumatra
Bybit Indonesia Supports Post-Flood Education Recovery in North Sumatra
Bybit Indonesia Supports Post-Flood Education Recovery in North Sumatra
- Dr. Jean-Luc Herbeaux appointed Chief Executive Officer of CordenPharma, effective 1 October 2026
- Dr. Michael Quirmbach to transition from President & CEO to Board Member and Senior Advisor, remaining actively involved with CordenPharma
- Planned leadership transition builds on 12 years of significant growth and transformation under Dr. Quirmbach's leadership
BASEL, Switzerland, Sept. 15, 2026 /PRNewswire/ -- CordenPharma, a leading global pharmaceutical CDMO, announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Executive Officer, effective 1 October 2026, as the company enters its next phase of growth.
Dr. Herbeaux will succeed Dr. Michael Quirmbach, who has served as CordenPharma's Chief Executive Officer since 2019 and has played a defining role in the company's growth and transformation over the past 12 years. As part of the planned leadership transition, Michael will remain actively involved with CordenPharma as a Board Member and Senior Advisor, bringing his deep knowledge of the company and industry expertise and providing strategic guidance as the company enters its next phase.
Dr. Jean-Luc Herbeaux appointed Chief Executive Officer
Dr. Herbeaux joins CordenPharma from Hovione, an international CDMO, where he served as Chief Executive Officer for more than four years. Prior to becoming CEO, he served as Chief Operating Officer at Hovione and previously held several senior roles at Evonik, a global leader in specialty chemicals and sustainable material technologies.
As Chief Executive Officer, Dr. Herbeaux will lead the execution of CordenPharma's long-term strategy, working closely with the Board and with the continued support of Astorg, with a focus on continued growth, operational execution, customer delivery and the further development of the company's global platform.
His appointment comes as CordenPharma enters a new stage of development following a period of significant strategic expansion and investment. This includes the recent acquisition of peptide CDMO AmbioPharm and continued investment in development and manufacturing capacity across its network. Today, CordenPharma employs approximately 3,500 people and operates an expanded manufacturing network across the US, Europe and Asia, supporting customers from early development through commercial manufacturing.
Building on 12 years of growth under Dr. Michael Quirmbach
Dr. Quirmbach joined CordenPharma in 2014 and became Chief Executive Officer in 2019. During his tenure, he played a defining role in CordenPharma's transformation into a leading global CDMO. He oversaw the development of a focused platform strategy, significant investment in capabilities and capacity, the expansion of CordenPharma's global footprint and the integration of its sites. He also helped build a strongly customer-focused organisation and foster a culture of collaboration and entrepreneurial spirit across the business.
Over Michael's 12 years with the company, CordenPharma grew from €245 million in annual revenue to more than €1 billion.
Judith Charpentier, Co-Managing Partner & Co-Head of Flagship said:
"Michael has made an exceptional contribution to CordenPharma over the past 12 years, playing a defining role in building the global CDMO it is today. We are deeply grateful for his leadership and partnership, and very pleased that he will remain involved with the business. Jean-Luc brings deep CDMO leadership and operational experience, and we look forward to working closely with him and the wider team to build on these strong foundations, continue serving customers globally and support the medicines they bring to patients."
Dr. Jean-Luc Herbeaux, incoming Chief Executive Officer, said:
"I am excited to join CordenPharma and work alongside Astorg at a defining stage of the company's development. I have great respect for what Michael and the team have built and see significant opportunities ahead. My focus will be clear: execute our growth plans with discipline, deepen our partnerships with customers and continue strengthening the capabilities they rely on to develop and manufacture critical medicines for patients around the world."
Dr. Michael Quirmbach, Board Member and Senior Advisor, CordenPharma said:
"I am incredibly proud of what we have built together at CordenPharma over the past 12 years and grateful to the many colleagues, customers and partners who have been part of that journey. The company is in a strong position for its next phase of development, and I look forward to continuing to contribute as Board Member and Senior Advisor."
About CordenPharma
CordenPharma is a CDMO supporting and partnering with biotech and pharma innovators of complex modalities in the advancement of their drug development lifecycle. Harnessing the collective expertise of the teams across its globally integrated facility network, CordenPharma provides bespoke outsourcing services spanning the complete supply chain, from early clinical-phase development to commercialization.
With scientific expertise and partnership at its core, CordenPharma provides customers with high-value, end-to-end services with a strategic focus on Peptides, Small Molecules (both Highly Potent and Regular Potency), customized Lipid Excipients, Lipid NanoParticles (LNPs), sterile Injectables, and Oligonucleotides.
The CordenPharma Group is comprised of 13 facilities across Europe, North America and Asia with more than 3,500 employees. In the 2025 financial year, the organization generated sales of €960 million. In 2022, CordenPharma was acquired by Astorg - a leading Pan-European private equity firm with deep expertise in the healthcare sector - to accelerate its development and further strengthen its leadership in the CDMO space.
Please visit cordenpharma.com for more information I Follow CordenPharma on LinkedIn.
About Astorg
Astorg is a leading pan-European private equity firm with over €24 billion of assets under management. Astorg is a multi-specialist investor with deep expertise in healthcare, technology and business services. Within healthcare, Astorg concentrates on a narrow set of subsectors: pharmaceutical services and technology, MedTech and MedTech services, life science tools, and diagnostics. Enjoying a distinct entrepreneurial culture, an engaged shareholder perspective and a lean decision making body, Astorg works with founders, entrepreneurs and management teams to acquire premium international B2B businesses, providing them with strategic guidance, governance and capital to enhance their strategic positioning and achieve their financial objectives. Headquartered in Luxembourg, Astorg has offices in London, Paris, New York, Frankfurt, and Milan.
For more information about Astorg: www.astorg.com | Follow Astorg on LinkedIn
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
CordenPharma Appoints Dr. Jean-Luc Herbeaux as Chief Executive Officer to Lead Next Phase of Growth
